How should I treat a patient with life-threatening gastrointestinal bleeding early after coronary drug-eluting stent implantation?

BACKGROUND A 68-year-old man was referred for stable angina pectoris and a large apical perfusion defect on stress myocardial scintigraphy. Medical history included chronic oral anticoagulation with warfarin due to longstanding atrial fibrillation, type 2 diabetes mellitus, hypertension, and dyslipidaemia. INVESTIGATION Coronary angiography. DIAGNOSIS Severe stenosis of the mid left anterior descending coronary artery. TREATMENT Percutaneous coronary intervention with implantation of drug-eluting stent.

[1]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[2]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[3]  M. Pocard,et al.  Treatment of gastrointestinal angiodysplasia and unmet needs. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[4]  G. Lip,et al.  Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort , 2010, Stroke.

[5]  Fredrik Folke,et al.  Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. , 2010, Archives of internal medicine.

[6]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[7]  F. Feit,et al.  Optimizing antithrombotic strategies in patients with concomitant indications for warfarin undergoing coronary artery stenting. , 2009, The American journal of cardiology.

[8]  Maurice Buchbinder,et al.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[9]  D. Holmes,et al.  Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. , 2009, Journal of the American College of Cardiology.

[10]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[11]  A. Gavazzi,et al.  Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. , 2008, The American journal of cardiology.

[12]  Jeffrey L. Anderson,et al.  2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. , 2008, Journal of the American College of Cardiology.

[13]  Jeffrey L. Anderson,et al.  2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  J. Boura,et al.  Impact of Acute Blood Loss Anemia and Red Blood Cell Transfusion on Mortality after Percutaneous Coronary Intervention , 2007, Clinical cardiology.

[15]  J. Gardin,et al.  Blood Transfusion and In‐hospital Outcomes in Anemic Patients with Myocardial Infarction Undergoing Percutaneous Coronary Intervention , 2007, Clinical cardiology.

[16]  M. Bulsara,et al.  Predictive and Protective Factors Associated With Upper Gastrointestinal Bleeding After Percutaneous Coronary Intervention: A Case-Control Study , 2007, The American Journal of Gastroenterology.

[17]  G. Scaglione,et al.  Long‐acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia , 2007, Alimentary pharmacology & therapeutics.

[18]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[19]  J. Olmos,et al.  Long-Term Outcome of Argon Plasma Ablation Therapy for Bleeding in 100 Consecutive Patients with Colonic Angiodysplasia , 2006, Diseases of the colon and rectum.

[20]  N. Suzuki,et al.  A novel method of treating colonic angiodysplasia. , 2006, Gastrointestinal endoscopy.

[21]  M. Pfeffer,et al.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.

[22]  M. Henríquez,et al.  Argon Plasma Coagulation in the Management of Symptomatic Gastrointestinal Vascular Lesions: Experience in 100 Consecutive Patients with Long-Term Follow-Up , 2006, The American Journal of Gastroenterology.

[23]  B. Moparty,et al.  Role of hemoclips in a patient with cecal angiodysplasia at high risk of recurrent bleeding from antithrombotic therapy to maintain coronary stent patency: a case report. , 2005, Gastrointestinal endoscopy.

[24]  I. Iakovou,et al.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[25]  E. Rondonotti,et al.  Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: report of 100 consecutive cases. , 2004, Gastroenterology.

[26]  N. Weissman,et al.  Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. , 2003, The American journal of cardiology.

[27]  J. Malagelada,et al.  A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. , 2001, Gastroenterology.

[28]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[29]  J. Malagelada,et al.  Long-Term Efficacy of Octreotide in the Prevention of Recurrent Bleeding from Gastrointestinal Angiodysplasia , 2001, The American Journal of Gastroenterology.

[30]  S. Pocock,et al.  A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting , 1998 .

[31]  D. Lieberman,et al.  Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. , 1995, The American journal of gastroenterology.

[32]  Foutch Pg.  Angiodysplasia of the gastrointestinal tract. , 1993 .

[33]  G. Colditz,et al.  Angiodysplasia : natural history and efficacy of therapeutic interventions , 1989 .

[34]  V. Sreenivas,et al.  Controlled, semielective, segmental resection for massive colonic hemorrhage. , 1980, American journal of surgery.

[35]  M. Cappell,et al.  Safety and efficacy of esophagogastroduodenoscopy after myocardial infarction. , 1999, The American journal of medicine.